Vyriad Alternatives & Competitors
12 companies similar to Vyriad — Vyriad is a clinical-stage biotech company developing targeted genetic therapies...
Companies similar to Vyriad
Prescient Therapeutics
A clinical stage oncology company developing personalised medicine approaches to cancer; c...
Atea Pharmaceuticals, Inc
Discovery & development of breakthrough therapies for COVID-19 patients and severe viral d...
Xilio Therapeutics, Inc.
Focused on harnessing the immune system to achieve deep and durable clinical responses to...
克睿基因 Cure Genetics
Benifiting Lives with Genetic Engineering
Rival Readout
Competing with Vyriad? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Antharis Therapeutics, Inc.
Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting...
BreezeBio
Genetic Medicine Delivered
Be Biopharma
Engineered B cells as medicines
ViraTherapeutics GmbH
We make cancer immunotherapies more powerful.
Alterome Therapeutics, Inc
To Life!
Pepkon
Pioneering breakthrough peptides for treating challenging cancers with precision and hope.
Virogin Biotech
Virotherapy to Ignite Immunotherapy
About Vyriad
Vyriad, a United States-based clinical-stage biotech company, is making strides in the biotechnology sector by pioneering targeted genetic therapies. These therapies are designed to deliver genes directly to cells using engineered viruses, viral vectors, and envelope glycoproteins. The company's technology is tailored...
Development of Viral Platforms, Manufacturing of Genetic Therapies, Preclinical and Clinical Trial Management, Collaborative Research and Development
Medical Institutions, Pharmaceutical Companies, Research Organizations, Healthcare Organizations
Biotech, Genetic Therapies, Oncolytic Virotherapy, Viral Vectors, Gene Editing, Cancer Treatment, Phase 1-2 Clinical Studies, Targeted Cell Therapy, Immuno-Oncology, Clinical Research Collaboration, Proprietary Oncolytic Virus, Non-Small Cell Lung Cancer, Metastatic Colorectal Cancer, Squamous Cell Carcinoma
B2B
Licensing, Performance Based, Project Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Vyriad: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Vyriad on 11 Mar 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.